Health

Serum Institute Of India Gets DCGI Nod For Phase 2, 3 Trials Of Oxford Vaccine

The Drug Controller General Of India (DCGI) V.G. Somani on Tuesday gave approval to the Serum Institute of India (SII) for conducting Phase II and Phase III clinical trials of Oxford University-AstraZeneca COVID-19 vaccine COVISHIELD. The SII is manufacturing the vaccine developed by the Jenner...